Simi Valley, CA, United States of America

Archana Neergunda

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Archana Neergunda. Retrieved from https://idiyas.com/inventor/archana-neergunda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Archana Neergunda: Innovator in Pharmaceutical Synthesis

Introduction

Archana Neergunda is a prominent inventor based in Simi Valley, CA (US). She has made significant contributions to the field of pharmaceutical synthesis, holding a total of 3 patents. Her work focuses on innovative methods that enhance drug development processes.

Latest Patents

One of her latest patents includes the synthesis of omecamtiv mecarbil. This patent provides a detailed synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. This innovation is crucial for advancing treatments in cardiovascular health.

Career Highlights

Archana is currently employed at Amgen Inc., a leading biotechnology company. Her role involves extensive research and development, contributing to the creation of new therapeutic solutions. Her expertise in synthesis has positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Archana has collaborated with notable colleagues, including Sebastien Caille and Kyle Quasdorf. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Archana Neergunda's contributions to pharmaceutical synthesis exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…